Sign in to continue:

Tuesday, March 24th, 2026

Day: March 23, 2026

Xilio Therapeutics: Advancing Masked Immuno-Oncology Therapies for Improved Cancer Outcomes

Xilio Therapeutics 2025 Annual Report: Key Investor Highligh...

Bally’s Corporation 2025 10-K: Business Segments, Acquisitions, and Financial Reporting Overview

Financial Report Analysis: Key Investor Insights from Bally'...

Xtrackers II Annual General Meeting 2026: Agenda, Voting, and Shareholder Information

Xtrackers II Announces Key Details for 2026 AGM: Re-Election...